Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.

Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.

Influenza viruses have acquired resistance to approved neuraminidase-targeting drugs, increasing the need for new drug targets for the development of novel anti-influenza drugs. Nucleoprotein (NP) is an attractive target since it has an indispensable role in virus replication and its amino acid sequ...

Full description

Bibliographic Details
Main Authors:	Juliann Nzembi Makau, Ken Watanabe, Takeshi Ishikawa, Satoshi Mizuta, Tsuyoshi Hamada, Nobuyuki Kobayashi, Noriyuki Nishida
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5342234?pdf=render

Similar Items

A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants
by: Juliann Nzembi Makau, et al.
Published: (2020-03-01)

Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors—In Vitro, In Silico and QSAR Studies
by: Radoslav Chayrov, et al.
Published: (2020-09-01)

In vitro and in silico Evaluation of Some Natural Molecules as Potent Glutathione Reductase Inhibitors
by: Tuba Aydin
Published: (2020-01-01)

Benzopyrazine-Based Small Molecule Inhibitors As Trypanocidal and Leishmanicidal Agents: Green Synthesis, In Vitro, and In Silico Evaluations
by: Jonathan Rock, et al.
Published: (2021-09-01)

Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
by: Daisuke Ishibashi, et al.
Published: (2016-07-01)

Small Molecule Inhibitors of Influenza Virus Entry
by: Zhaoyu Chen, et al.
Published: (2021-06-01)

Functional Study of the N-terminal of Influenza B Nucleoprotein and In-silico Screening of Inhibitors Targeting Influenza Polymerase
Published: (2016)

Locking the 150-cavity open: in silico design and verification of influenza neuraminidase inhibitors.
by: Nanyu Han, et al.
Published: (2013-01-01)

Inhibition of influenza A virus infection in vitro by peptides designed in silico.
by: Rogelio López-Martínez, et al.
Published: (2013-01-01)

Elucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches
by: Minjee Kim, et al.
Published: (2021-08-01)

Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies
by: Morgan Robinson, et al.
Published: (2021-01-01)

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
by: Z. Ping Lin, et al.
Published: (2021-04-01)

In vitro and in vivo Evaluation of in silico Predicted Pneumococcal UDPG:PP Inhibitors
by: Freya Cools, et al.
Published: (2020-07-01)

Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches
by: Katalin Szilágyi, et al.
Published: (2019-10-01)

Study of potential xanthine oxidase inhibitors: In silico and in vitro biological activity
by: Muthuswamy Umamaheswari, et al.
Published: (2011-12-01)

In silico identification of apobec3b small molecule inhibitors from dtp-nci libraries
by: Adenan, M.I, et al.
Published: (2021)

SARS-CoV-2: Virology and Drug Repurposing Approaches
by: Ratika Rahmasari, et al.
Published: (2020-07-01)

Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening
by: Ahmed Elkamhawy, et al.
Published: (2021-09-01)

In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives
by: Hee Jin Jung, et al.
Published: (2019-01-01)

New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies
by: Mehreen Lateef, et al.
Published: (2017-07-01)

Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.
by: Cinzia Colombo, et al.
Published: (2018-01-01)

In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease
by: Ryunosuke Yoshino, et al.
Published: (2017-07-01)

The feasibility and correlation of commercial protein hydrolysates as ACE inhibitor between in silico and in vitro analyses
by: Jen-Chieh Li, et al.
Published: (2018)

Rational Design, Synthesis, In Vitro, and In Silico Studies of Dihydropyrimidinone Derivatives as β-Glucuronidase Inhibitors
by: Somaye Karimian, et al.
Published: (2021-01-01)

Discovery of Natural Inhibitors of Cholinesterases from <i>Hydrangea</i>: In Vitro and In Silico Approaches
by: Jayeong Hwang, et al.
Published: (2021-01-01)

Acetylcholinesterase Choline-Based Ionic Liquid Inhibitors: In Vitro and in Silico Molecular Docking Studies
by: Filipa Siopa, et al.
Published: (2018-12-01)

In silico and in vitro insights into tyrosinase inhibitors with a 2-thioxooxazoline-4-one template
by: Inkyu Choi, et al.
Published: (2021-01-01)

Evaluation of caffeine as inhibitor against collagenase, elastase and tyrosinase using in silico and in vitro approach
by: Kyung Eun Lee, et al.
Published: (2019-01-01)

IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening.
by: Naomi Tidten-Luksch, et al.
Published: (2012-01-01)

Novel Natural Inhibitors of CYP1A2 Identified by in Silico and in Vitro Screening
by: Zhiwei Cao, et al.
Published: (2011-05-01)

In Silico and in Vitro-Guided Identification of Inhibitors of Alkylquinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa
by: Fadi Soukarieh, et al.
Published: (2018-01-01)

In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
by: Fabian C. Herrmann, et al.
Published: (2017-12-01)

Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
by: Thitinan Aiebchun, et al.
Published: (2021-04-01)

In Silico Screening and Experimental Evaluation of Small Molecule Inhibitors Against HCV NS3/4A Protease
by: Hoang-Chinh Nguyen, et al.
Published: (2015)

Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
by: Eleni Pitsillou, et al.
Published: (2020-12-01)

The validity and correlation of dietary protein hydrolysate as β-secretase inhibitor between in silico and in vitro analyses
by: Xiao-Jun Su, et al.
Published: (2017)

In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors
by: Emanuele Criscuolo, et al.
Published: (2021-12-01)

The insight of in vitro and in silico studies on cholinesterase inhibitors from the roots of Cimicifuga dahurica (Turcz.) Maxim.
by: Jang Hoon Kim, et al.
Published: (2018-01-01)

In Silico Screening and In Vitro Activity Measurement of Javamide Analogues as Potential p38 MAPK Inhibitors
by: Jae B. Park
Published: (2017-12-01)

Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
by: Ranajit Nivrutti Shinde, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_nbemats26dq5fnfksq2bbslto9